Latest Market Expansion News

Page 8 of 111
Orbital Corporation broadened its international footprint with new UAV propulsion orders across the US, India, and Middle East, while advancing its Power by the Hour service to underpin recurring revenue streams.
Victor Sage
Victor Sage
31 July 2026
OncoSil Medical reported a 53% increase in unit sales and advanced key regulatory approvals, including FDA final review and TGA listing, positioning it for growth in pancreatic cancer treatment.
Ada Torres
Ada Torres
30 July 2026
PainChek lifted implemented ARR by 5.9% to $4.46 million and secured its first US commercial contracts under a major Sabra REIT agreement, boosting customer receipts 27% in the June quarter.
Ada Torres
Ada Torres
29 July 2026
De.mem Limited posted its second highest quarterly cash receipts of approximately $9.6 million for June 2026, marking 29 consecutive quarters of growth and positive operating cash flow of $424k. The company’s strong half-year performance is underpinned by recurring revenues, a robust Western Australian business, and record results from its German subsidiary.
Victor Sage
Victor Sage
29 July 2026
Nodestream has advanced its defence strategy with key leadership hires, a $6.5 million capital raise, and fresh product launches, while expanding its footprint in the US and European markets.
Sophie Babbage
Sophie Babbage
29 July 2026
Biome Australia capped FY26 with record $23.9 million sales and its flagship probiotic topping Australian pharmacy charts. The company signed an onshore manufacturing deal and expanded its proprietary probiotic clinical trial internationally.
Ada Torres
Ada Torres
29 July 2026
RLF AgTech posted a seasonally strong June quarter with $7.1 million in cash receipts, driven by record pre-season payments in China and tight cost control that brought operating cash flow close to breakeven.
Ada Torres
Ada Torres
28 July 2026
The Calmer Co International Ltd is raising up to $3.5 million through a 1-for-1 renounceable entitlement offer priced at $0.001 per share, including free attaching options exercisable at $0.002. The capital will fund debt repayment, inventory expansion, marketing, and product launches.
Victor Sage
Victor Sage
27 July 2026
Lumos Diagnostics reported a 6% revenue increase to US$13.2 million for FY26, driven by an 875% surge in FebriDx® sales following a pivotal CLIA waiver. The company expanded U.S. adoption to 170+ healthcare sites and secured milestone payments exceeding US$6 million.
Ada Torres
Ada Torres
27 July 2026
Electro Optic Systems (ASX:EOS) posted a 284% surge in first-half 2026 revenue to $169 million, driven by robust defence contracts and regional tensions. Its order book hit a historic $846 million, prompting an upgrade to full-year guidance and signalling strong momentum in counter-drone and laser weapon systems.
Victor Sage
Victor Sage
27 July 2026
Yowie Group has doubled its half-year profit to US$0.9 million amid a 16% revenue decline, driven by a US customer range cut and elevated cocoa costs impacting Australia. The confectionery maker advances its turnaround with new product launches and legal wins, while navigating ongoing funding and legacy loan challenges.
Victor Sage
Victor Sage
24 July 2026
Eden Innovations has secured robust validation from India’s Central Road Research Institute showing its EdenCrete®Pz7 carbon nanotube admixture boosts concrete strength, durability, and sustainability in key infrastructure mixes.
Victor Sage
Victor Sage
22 July 2026

Browse the archive

Full archive